Christopher Pepin

Christopher Pepin is a highly experienced bioinformatician currently serving as Principal Scientist at Orna Therapeutics since June 2024, following the acquisition of ReNAgade Therapeutics, where Pepin held the position of Scientist II. Prior to this, significant roles at Moderna included Scientist and Principal Research Associate in bioinformatics, contributing to various projects from December 2017 until September 2023. Earlier experience includes work as a Statistical Analyst at BioStat Solutions, Inc., focusing on statistical analyses and programming in R and SAS, as well as a Graduate Research Assistant at the University of Maryland, Baltimore, developing public health research. Educational qualifications include a Master's degree in Epidemiology from the University of Maryland and a Bachelor of Science in Biology from Saint Michael's College.